AFP and hepatocellular carcinoma: The median survival times of patients in these four groups (NBNC-AFP(+)/(-)-HCC groups and B-AFP(+)/(-)-HCC groups) were 1 year, 10 years, 2 years, and 4 years, and their 1-year OS rates were 83.9%, 80.1%, 66.4%, and 82.2%, respectively.